Altrova Health (XCNQ:ROVA) ROCE %: -116.37% (As of Mar. 2026)


What is Altrova Health ROCE %?

Altrova Health XCNQ:ROVA -10.00% ROCE % is -116.37% as of Mar. 2026. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Altrova Health's annualized ROCE % for the quarter that ended in Mar. 2026 was -116.37%.

Altrova Health  (XCNQ:ROVA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Altrova Health ROCE % Related Terms

Altrova Health ROCE % Historical Data

* Premium members only.

The historical data trend for Altrova Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Altrova Health ROCE % Chart

Altrova Health Annual Data
Trend Sep23 Sep24 Sep25
ROCE %
-323.39 -376.59 -116.89

Altrova Health Quarterly Data
Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -75.71 -30.45 -52.32 -52.32 -116.37

Altrova Health ROCE % Calculation

Altrova Health's annualized ROCE % for the fiscal year that ended in Sep. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Sep. 2025 )  (A: Sep. 2024 )(A: Sep. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Sep. 2025 )  (A: Sep. 2024 )(A: Sep. 2025 )
=-1.599/( ( (0.895 - 0.551) + (3.248 - 0.856) )/ 2 )
=-1.599/( (0.344+2.392)/ 2 )
=-1.599/1.368
=-116.89 %

Altrova Health's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-3.12/( ( (3.981 - 0.975) + (3.81 - 1.454) )/ 2 )
=-3.12/( ( 3.006 + 2.356 )/ 2 )
=-3.12/2.681
=-116.37 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -116.37% mean?
Altrova Health (XCNQ:ROVA) has a ROCE % of -116.37% as of Mar. 2026.
Is Altrova Health's ROCE % too high?
Altrova Health's current ROCE % is -116.37%.
How does Altrova Health's ROCE % compare to BLK and BX?
Altrova Health's ROCE % of -116.37% can be compared against companies in the Asset Management industry. The industry median ROCE % is 4.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for an Asset Management company?
The median ROCE % among Asset Management companies is 4.46, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Asset Management industry, the median ROCE % is 4.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Altrova Health's current ROCE % is -116.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Altrova Health stock overvalued right now?
Altrova Health (XCNQ:ROVA) has a current ROCE % of -116.37%. The current ROCE % is -116.37%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Altrova Health (XCNQ:ROVA), the current ROCE % is -116.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Altrova Health Business Description

Other Exchanges SSPLF:USA
Address 666 Burrard Street, 25th Floor, Vancouver, BC, CAN, V6C 2X8
Altrova Health Inc is a Canadian public company building a growing portfolio of health solutions across detection, protection, treatment, and wellness. The Company is focused on supporting multiple products, brands, and growth pathways under one stronger corporate identity, expanding beyond any single product story to create a more durable business. The Company continues to evaluate opportunities to expand its product offerings across the public health and safety sector.